propofol has been researched along with Cardiovascular Stroke in 39 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to investigate the protective effect of propofol on the experimental myocardial infarction in rats." | 8.02 | [The myocardial protective effect of propofol on rats with experimental myocardial infarction and its mechanism]. ( Liu, JL; Tian, QX; Zhang, MX, 2021) |
| "To investigate the effects of propofol, midazolam and thiopental sodium on outcomes and amino acid accumulation in focal cerebral ischemia-reperfusion in rats." | 7.72 | Effects of propofol, midazolam and thiopental sodium on outcome and amino acids accumulation in focal cerebral ischemia-reperfusion in rats. ( Chen, L; Gong, Q; Xiao, C, 2003) |
| "In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during isoflurane/sufentanil or propofol/sufentanil anesthesia with or without RIPC (three 5-min periods of intermittent left upper arm ischemia with 5 min reperfusion each) in non-diabetic patients (n = 72) with three-vessel coronary artery disease (ClinicalTrials." | 5.16 | Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. ( Bergmann, L; Heine, T; Heusch, G; Jakob, H; Kottenberg, E; Peters, J; Thielmann, M, 2012) |
| " There was no difference in the incidence of breakthrough hypertension between the two groups (in 44% and 43% of the patients, respectively) and in the number of alfentanil bolus supplements." | 5.08 | Continuous infusions of alfentanil and propofol for coronary artery surgery. ( de Lange, S; Gerrits, HJ; Roekaerts, PM; Timmerman, BE, 1995) |
| " Cardiac morbidity (postoperative myocardial ischemia, postoperative myocardial infarction, and perioperative sympathoadrenal stress response), respiratory morbidity (postextubation apnea, alveolar-arterial oxygen gradient, pulmonary shunting, oxygen consumption, atelectasis, and reintubation), hemodynamic values and vasoactive medication requirements, intraoperative awareness, postoperative cognitive function, 30 day mortality, and intensive care unit and hospital lengths of stay were compared between the two groups." | 5.08 | Morbidity outcome in early versus conventional tracheal extubation after coronary artery bypass grafting: a prospective randomized controlled trial. ( Asokumar, B; Carroll, J; Cheng, DC; David, T; Karski, J; Mickle, D; Nierenberg, H; Peniston, C; Raveendran, G; Roger, S; Sandler, A; Tong, J; Zelovitsky, J, 1996) |
| " Thirty-day complication rates were compared with EGD under sedation or not, type of sedation drugs (midazolam only vs midazolam/propofol) and age groups (18-64 year vs ≥65 year) for GI (bleeding and perforation) and non-GI complications (pneumonia, acute myocardial infarction, congestive heart failure and cerebral stroke)." | 4.12 | Gastrointestinal and non-gastrointestinal complication rates associated with diagnostic esophagogastroduodenoscopy under sedation. ( Cha, JM; Jang, JM; Kwak, MS; Park, SB; Yoon, JY, 2022) |
| "The aim of the present study was to investigate the protective effect of propofol on the experimental myocardial infarction in rats." | 4.02 | [The myocardial protective effect of propofol on rats with experimental myocardial infarction and its mechanism]. ( Liu, JL; Tian, QX; Zhang, MX, 2021) |
| " Propofol was given to patients reporting pain or discomfort throughout the procedure." | 3.81 | Incidence of and indications for conversion of cervical plexus block to general anesthesia in patients undergoing carotid surgery: a single center experience. ( Davidovic, LB; Koncar, I; Kostic, D; Lucic, M; Sindjelic, RP; Vlajkovic, GP, 2015) |
| "To investigate the effects of propofol, midazolam and thiopental sodium on outcomes and amino acid accumulation in focal cerebral ischemia-reperfusion in rats." | 3.72 | Effects of propofol, midazolam and thiopental sodium on outcome and amino acids accumulation in focal cerebral ischemia-reperfusion in rats. ( Chen, L; Gong, Q; Xiao, C, 2003) |
| "Propofol (PPF) has a protective effect on myocardial ischemia-reperfusion (I/R) injury (MIRI)." | 1.72 | Propofol pretreatment alleviates mast cell degranulation by inhibiting SOC to protect the myocardium from ischemia-reperfusion injury. ( Guan, X; Juan, Z; Li, Y; Ma, R; Meng, Y; Sun, X; Wang, M, 2022) |
| "Desflurane had lower uptake than propofol (65 ± 21 × 10 vs 165 ± 51 × 10 g·mL·min/μmol; P = ." | 1.48 | Propofol Attenuates the Myocardial Protection Properties of Desflurane by Modulating Mitochondrial Permeability Transition. ( Andrews, DT; Heiberg, J; Royse, AG; Royse, CF, 2018) |
| "Isoflurane was inhaled at 1 MAC (0." | 1.35 | Cardioprotective effects of anesthetic preconditioning in rats with ischemia-reperfusion injury: propofol versus isoflurane. ( Li, SR; Lin, MT; Lu, LQ; Tao, X; Xu, Q, 2009) |
| "An esmolol infusion was started to control his persistent tachycardia but this depressed his myocardial contractility." | 1.29 | Thyrotoxicosis factitia in a post-aortocoronary bypass patient. ( Karski, JM; Redahan, C, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (10.26) | 18.2507 |
| 2000's | 17 (43.59) | 29.6817 |
| 2010's | 9 (23.08) | 24.3611 |
| 2020's | 9 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, X | 1 |
| Yan, M | 1 |
| Zhang, MX | 1 |
| Tian, QX | 1 |
| Liu, JL | 1 |
| Zangrillo, A | 1 |
| Lomivorotov, VV | 1 |
| Pasyuga, VV | 1 |
| Belletti, A | 1 |
| Gazivoda, G | 1 |
| Monaco, F | 1 |
| Nigro Neto, C | 1 |
| Likhvantsev, VV | 1 |
| Bradic, N | 1 |
| Lozovskiy, A | 1 |
| Lei, C | 1 |
| Bukamal, NAR | 1 |
| Silva, FS | 1 |
| Bautin, AE | 1 |
| Ma, J | 1 |
| Yong, CY | 1 |
| Carollo, C | 1 |
| Kunstyr, J | 1 |
| Wang, CY | 1 |
| Grigoryev, EV | 1 |
| Riha, H | 1 |
| Wang, C | 2 |
| El-Tahan, MR | 1 |
| Scandroglio, AM | 1 |
| Mansor, M | 1 |
| Lembo, R | 1 |
| Ponomarev, DN | 1 |
| Bezerra, FJL | 1 |
| Ruggeri, L | 1 |
| Chernyavskiy, AM | 1 |
| Xu, J | 1 |
| Tarasov, DG | 1 |
| Navalesi, P | 1 |
| Yavorovskiy, A | 1 |
| Bove, T | 1 |
| Kuzovlev, A | 1 |
| Hajjar, LA | 1 |
| Landoni, G | 1 |
| Cho, YJ | 1 |
| Jung, DE | 1 |
| Nam, K | 1 |
| Bae, J | 1 |
| Lee, S | 1 |
| Jeon, Y | 1 |
| Jang, JM | 1 |
| Park, SB | 1 |
| Yoon, JY | 1 |
| Kwak, MS | 1 |
| Cha, JM | 1 |
| Li, Y | 1 |
| Sun, X | 1 |
| Juan, Z | 1 |
| Guan, X | 1 |
| Wang, M | 1 |
| Meng, Y | 1 |
| Ma, R | 1 |
| Heybati, K | 1 |
| Zhou, F | 1 |
| Baltazar, M | 1 |
| Poudel, K | 1 |
| Ochal, D | 1 |
| Ellythy, L | 1 |
| Deng, J | 1 |
| Chelf, CJ | 1 |
| Welker, C | 1 |
| Ramakrishna, H | 1 |
| Lotz, C | 2 |
| Stumpner, J | 2 |
| Smul, TM | 2 |
| Jing, H | 1 |
| Zhao, L | 1 |
| Cheng, J | 1 |
| Qin, P | 1 |
| Lin, H | 1 |
| Heusch, G | 2 |
| Behmenburg, F | 1 |
| van Caster, P | 1 |
| Bunte, S | 1 |
| Brandenburger, T | 1 |
| Heinen, A | 1 |
| Hollmann, MW | 1 |
| Huhn, R | 1 |
| Meybohm, P | 1 |
| Kohlhaas, M | 1 |
| Stoppe, C | 1 |
| Gruenewald, M | 1 |
| Renner, J | 1 |
| Bein, B | 1 |
| Albrecht, M | 1 |
| Cremer, J | 1 |
| Coburn, M | 1 |
| Schaelte, G | 1 |
| Boening, A | 1 |
| Niemann, B | 1 |
| Sander, M | 1 |
| Roesner, J | 1 |
| Kletzin, F | 1 |
| Mutlak, H | 1 |
| Westphal, S | 1 |
| Laufenberg-Feldmann, R | 1 |
| Ferner, M | 1 |
| Brandes, IF | 1 |
| Bauer, M | 1 |
| Stehr, SN | 1 |
| Kortgen, A | 1 |
| Wittmann, M | 1 |
| Baumgarten, G | 1 |
| Meyer-Treschan, T | 1 |
| Kienbaum, P | 1 |
| Heringlake, M | 1 |
| Schoen, J | 1 |
| Treskatsch, S | 1 |
| Smul, T | 1 |
| Wolwender, E | 1 |
| Schilling, T | 1 |
| Fuernau, G | 1 |
| Bogatsch, H | 1 |
| Brosteanu, O | 1 |
| Hasenclever, D | 1 |
| Zacharowski, K | 1 |
| Heiberg, J | 1 |
| Royse, CF | 2 |
| Royse, AG | 2 |
| Andrews, DT | 2 |
| Gajardo, AIJ | 1 |
| Karachon, L | 1 |
| Bustamante, P | 1 |
| Repullo, P | 1 |
| Llancaqueo, M | 1 |
| Sánchez, G | 1 |
| Rodrigo, R | 1 |
| Sindjelic, RP | 1 |
| Vlajkovic, GP | 1 |
| Lucic, M | 1 |
| Koncar, I | 1 |
| Kostic, D | 1 |
| Davidovic, LB | 1 |
| Rasmussen, T | 1 |
| Follin, B | 1 |
| Kastrup, J | 1 |
| Christensen, TE | 1 |
| Hammelev, KP | 1 |
| Kjær, A | 1 |
| Hasbak, P | 1 |
| Shimony, A | 1 |
| Almog, Y | 1 |
| Zahger, D | 1 |
| Kamada, N | 1 |
| Kanaya, N | 1 |
| Hirata, N | 1 |
| Kimura, S | 1 |
| Namiki, A | 1 |
| Yildirim, V | 1 |
| Doganci, S | 1 |
| Aydin, A | 1 |
| Bolcal, C | 1 |
| Demirkilic, U | 1 |
| Cosar, A | 1 |
| Tao, X | 1 |
| Lu, LQ | 1 |
| Xu, Q | 1 |
| Li, SR | 1 |
| Lin, MT | 1 |
| Blomeyer, C | 1 |
| Redel, A | 1 |
| Lange, M | 1 |
| Roewer, N | 1 |
| Kehl, F | 1 |
| Kottenberg, E | 1 |
| Thielmann, M | 1 |
| Bergmann, L | 1 |
| Heine, T | 1 |
| Jakob, H | 1 |
| Peters, J | 1 |
| Sakabe, M | 1 |
| Fujiki, A | 1 |
| Inoue, H | 1 |
| Chen, L | 1 |
| Gong, Q | 1 |
| Xiao, C | 1 |
| Peláez, R | 1 |
| Hortal, FJ | 1 |
| Bastida, E | 1 |
| Barrio, JM | 1 |
| Riesgo, MJ | 1 |
| Kulkarni, A | 1 |
| Price, G | 1 |
| Saxena, M | 1 |
| Skowronski, G | 1 |
| Barrington, MJ | 1 |
| Kluger, R | 1 |
| Watson, R | 1 |
| Scott, DA | 1 |
| Harris, KJ | 1 |
| Maekawa, T | 1 |
| Cho, S | 1 |
| Takahashi, S | 1 |
| Hara, T | 1 |
| Tomiyasu, S | 1 |
| Makita, T | 1 |
| Sumikawa, K | 1 |
| Higuchi, H | 1 |
| Maeda, S | 1 |
| Miyawaki, T | 1 |
| Kohjitani, A | 1 |
| Mori, T | 1 |
| Ishida, R | 1 |
| Egusa, M | 1 |
| Shimada, M | 1 |
| Jakobsen, CJ | 1 |
| Berg, H | 1 |
| Hindsholm, KB | 1 |
| Faddy, N | 1 |
| Sloth, E | 1 |
| Choi, SU | 1 |
| Lee, HW | 1 |
| Lim, HJ | 1 |
| Yoon, SM | 1 |
| Chang, SH | 1 |
| Roekaerts, PM | 1 |
| Gerrits, HJ | 1 |
| Timmerman, BE | 1 |
| de Lange, S | 1 |
| Hawkins, WJ | 1 |
| Cohen, AT | 1 |
| Redahan, C | 1 |
| Karski, JM | 1 |
| Cheng, DC | 1 |
| Karski, J | 1 |
| Peniston, C | 1 |
| Asokumar, B | 1 |
| Raveendran, G | 1 |
| Carroll, J | 1 |
| Nierenberg, H | 1 |
| Roger, S | 1 |
| Mickle, D | 1 |
| Tong, J | 1 |
| Zelovitsky, J | 1 |
| David, T | 1 |
| Sandler, A | 1 |
| Pittarello, D | 1 |
| Bonato, R | 1 |
| Armellin, G | 1 |
| Sorbara, C | 1 |
| Hess, WC | 1 |
| Ohe, A | 1 |
| Bonome, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of TENS on Myocardial Protection in Patients Undergoing AVR[NCT03859115] | 30 participants (Actual) | Interventional | 2019-03-15 | Completed | |||
| Remote Ischaemic Preconditioning for Heart Surgery[NCT01067703] | Phase 3 | 1,400 participants (Actual) | Interventional | 2010-12-31 | Terminated | ||
| Effect of Remote Ischemic Preconditioning in Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery With Crystalloid Cardioplegic Arrest[NCT01406678] | Phase 2/Phase 3 | 1,204 participants (Actual) | Interventional | 2008-07-31 | Completed | ||
| Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study[NCT02635347] | 31 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
| Protection of Heart, Brain and Kidney by Remote Ischemic Preconditioning in Patients Undergoing Transcatheter Aortic Valve Implantation - a Randomized, Single-blind Study[NCT02080299] | Phase 2 | 100 participants (Actual) | Interventional | 2013-09-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
In patients with Clavien-Dindo >/= IIIb complications, number of such complications per patient. (NCT02635347)
Timeframe: Post-op days 0-30
| Intervention | Complications (Median) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 1 |
| Historical Control Cohort | 0 |
Number of days in hospital post-transplant. Starting at post-op day 0 and ending on the calendar date that the patient is leaves the hospital, dies, or post-op day 90, whichever is soonest. (NCT02635347)
Timeframe: Post-op days 0 up to 90 days
| Intervention | days (Median) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 13 |
| Historical Control Cohort | 10 |
Number of days in ICU post-transplant. Starting at post-op day 0 and ending on the calendar date that the patient is transferred out of ICU, dies, or post-op day 90, whichever is soonest. (NCT02635347)
Timeframe: Post-op days 0 up to 90 days
| Intervention | days (Median) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 3.5 |
| Historical Control Cohort | 4 |
Median intervention-related pain score during each of the post-operative interventions, in extubated patients who are able to communicate. Using the Numerical Rating Scale (NRS, Ferrieira-Valente MA PAIN Volume 152, 2011), patients were asked to rate their pain following the intervention on a scale of 0-10 with 0 being no pain experienced to 10 as the maximum pain felt. (NCT02635347)
Timeframe: Post-op days 1-4
| Intervention | scores on a scale (Median) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 5 |
Percentage of patients with functioning allograft at 90 days post-transplant (NCT02635347)
Timeframe: Post-op day 90
| Intervention | percentage of participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 90 |
| Historical Control Cohort | 98.41 |
Number of subjects that received fewer than 6 interventions,. (NCT02635347)
Timeframe: Pre-op - Post-op day 4
| Intervention | participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 9 |
Percentage of patients alive at 90 days post-transplant (NCT02635347)
Timeframe: Post-op day 90
| Intervention | percentage of participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 90.32 |
| Historical Control Cohort | 98.41 |
Proportion of enrolled liver recipients that complete all 6 remote ischemic conditioning (RIC) interventions. (NCT02635347)
Timeframe: Pre-op - Post-op day 4
| Intervention | percentage of participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 70.96 |
"Percentage of participants who developed Acute Kidney Injury (AKI)~Based on Kidney Disease - Improving Global Outcomes (KDIGO) criteria, AKI criteria are:~Stage 2:~- 2.0-2.9 fold rise in serum creatinine from baseline~Stage 3:~> 3.0 fold rise in serum creatinine from baseline, or~Serum creatinine of > 4.0 mg/dL, with an acute (<48 hours) increase of 0.3 mg/dL in serum creatinine or subacute (< 7 days) increase in serum creatinine of 0.5 mg/dL, or~Initiation of renal replacement therapy." (NCT02635347)
Timeframe: Post-op days 0-7
| Intervention | percentage of participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 20.0 |
| Historical Control Cohort | 25.86 |
"Percentage of participants who developed Early Allograft Dysfunction (EAD) which is defined as:~Aspartate Transaminase (AST) or Alanine Transaminase (ALT)> 2,000 U/L at any point within the first seven post-transplant days, or~Total Bilirubin (TB) > 10 mg/dL on postoperative day 7,or~International Normalized Ratio (INR)> 1.6 on postoperative day 7." (NCT02635347)
Timeframe: Post-op days 0-7
| Intervention | percentage of participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 23.3 |
| Historical Control Cohort | 39.68 |
"Percentage of Participants who developed Prolonged Respiratory Insufficiency (PRI) defined as:~Ventilator support for >2 postoperative days after transplant, or~Reintubation after extubation, within 7 days of transplant. Patients who require brief re-intubation for an endoscopic, radiologic, or surgical procedure would not be considered to have PRI if they are extubated within 2 days of the end of the procedure." (NCT02635347)
Timeframe: Post-op days 0-7
| Intervention | percentage of participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 33.3 |
| Historical Control Cohort | 28.57 |
"Percentage of patients with Clavien-Dindo >/= grade III b complications (Dindo D, Demartines N, Clavien P, Annals of Surgery 2004).~The Clavien-Dindo Complications grade ranges from Grade I (Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside) to Grade V (Death). Grade IIIb would be any intervention requiring general anesthesia." (NCT02635347)
Timeframe: Post-op days 0-30
| Intervention | percentage of participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 51.1 |
| Historical Control Cohort | 47.62 |
In patients who are receiving dialysis pre-op, time to discontinuation of dialysis, if occurring within 90 days of transplantation. (NCT02635347)
Timeframe: Post-op days 0-90
| Intervention | days (Median) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 2 |
| Historical Control Cohort | 15.5 |
- Withdrawal of consent due to discomfort/pain in the lower extremity (NCT02635347)
Timeframe: Pre-op - Post-op day 7
| Intervention | participants (Number) |
|---|---|
| Remote Ischemic Conditioning (RIC) Group | 6 |
| Historical Control Cohort | 0 |
3 reviews available for propofol and Cardiovascular Stroke
| Article | Year |
|---|---|
Appraisal of Postoperative Outcomes of Volatile and Intravenous Anesthetics: A Network Meta-Analysis of Patients Undergoing Cardiac Surgery.
Topics: Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Cardiac Surgical Procedures; Humans; Midaz | 2023 |
Remote Ischemic Conditioning in Cardiovascular Surgery.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Cardiac Surgical Procedures; Comorbidity; Humans; | 2017 |
[Remifentanil in heart surgery].
Topics: Analgesics; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Intrave | 2001 |
9 trials available for propofol and Cardiovascular Stroke
| Article | Year |
|---|---|
Effect of Volatile Anesthetics on Myocardial Infarction After Coronary Artery Surgery: A Post Hoc Analysis of a Randomized Trial.
Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Coronary Artery Bypass; Humans; Middle Aged | 2022 |
Effects of transcutaneous electrical nerve stimulation on myocardial protection in patients undergoing aortic valve replacement: a randomized clinical trial.
Topics: Animals; Aortic Valve; Humans; Myocardial Infarction; Propofol; Rats; Sevoflurane; Transcutaneous El | 2022 |
RIPHeart (Remote Ischemic Preconditioning for Heart Surgery) Study: Myocardial Dysfunction, Postoperative Neurocognitive Dysfunction, and 1 Year Follow-Up.
Topics: Anesthetics, Intravenous; Cardiac Surgical Procedures; Cognition; Double-Blind Method; Echocardiogra | 2018 |
Cardioprotective effects of sevoflurane, isoflurane, and propofol in coronary surgery patients: a randomized controlled study.
Topics: Administration, Inhalation; Aged; Anesthetics, Inhalation; Cardiotonic Agents; Coronary Artery Bypas | 2009 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intraveno | 2012 |
Epidural anesthesia for coronary artery bypass surgery compared with general anesthesia alone does not reduce biochemical markers of myocardial damage.
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenous; Biomarkers; Cardiomyopath | 2005 |
Continuous infusions of alfentanil and propofol for coronary artery surgery.
Topics: Alfentanil; Anesthesia, Intravenous; Anesthetics, Intravenous; Blood Pressure; Cardiac Output; Coron | 1995 |
Morbidity outcome in early versus conventional tracheal extubation after coronary artery bypass grafting: a prospective randomized controlled trial.
Topics: Aged; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Apnea; Catecholamines; | 1996 |
[Alterations in left ventricular-arterial coupling and mechanical efficiency produced by remifentanil during cardiac anesthesia].
Topics: Aged; Anesthetics, Intravenous; Aorta; Cardiovascular Agents; Combined Modality Therapy; Coronary Ar | 2001 |
27 other studies available for propofol and Cardiovascular Stroke
| Article | Year |
|---|---|
Comparing the impact on the prognosis of acute myocardial infarction critical patients of using midazolam, propofol, and dexmedetomidine for sedation.
Topics: Aged; Aged, 80 and over; Coronary Care Units; Critical Illness; Databases, Factual; Dexmedetomidine; | 2021 |
[The myocardial protective effect of propofol on rats with experimental myocardial infarction and its mechanism].
Topics: Animals; Cardiotonic Agents; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infa | 2021 |
Gastrointestinal and non-gastrointestinal complication rates associated with diagnostic esophagogastroduodenoscopy under sedation.
Topics: Aged; Conscious Sedation; Endoscopy, Digestive System; Humans; Hypnotics and Sedatives; Midazolam; M | 2022 |
Propofol pretreatment alleviates mast cell degranulation by inhibiting SOC to protect the myocardium from ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Calcium; Cell Degranulation; Mast Cells; Myocardial Infarction; Myocardial Reper | 2022 |
Sevoflurane as opposed to propofol anesthesia preserves mitochondrial function and alleviates myocardial ischemia/reperfusion injury.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Disease Models, Animal; Electron Transpo | 2020 |
Propofol protects cardiomyocytes from hypoxia/reoxygenation injury via regulating MALAT1/miR-206/ATG3 axis.
Topics: Animals; Apoptosis; Autophagy-Related Proteins; Cell Hypoxia; Cell Line; Disease Models, Animal; Dow | 2021 |
Impact of Anesthetic Regimen on Remote Ischemic Preconditioning in the Rat Heart In Vivo.
Topics: Analgesics, Opioid; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Disease Models, Anim | 2018 |
Propofol Attenuates the Myocardial Protection Properties of Desflurane by Modulating Mitochondrial Permeability Transition.
Topics: Anesthesia; Anesthetics, Intravenous; Animals; Cardiotonic Agents; Deoxyglucose; Desflurane; Drug Ad | 2018 |
Autonomic imbalance in cardiac surgery: A potential determinant of the failure in remote ischemic preconditioning.
Topics: Animals; Cardiac Surgical Procedures; Chronic Disease; Comorbidity; Heart; Humans; Ischemic Precondi | 2018 |
Incidence of and indications for conversion of cervical plexus block to general anesthesia in patients undergoing carotid surgery: a single center experience.
Topics: Aged; Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Carotid Arteries; Cervical | 2015 |
Myocardial perfusion of infarcted and normal myocardium in propofol-anesthetized minipigs using (82)Rubidium PET.
Topics: Anesthetics, Intravenous; Animals; Blood Flow Velocity; Coronary Circulation; Myocardial Infarction; | 2016 |
Propofol infusion syndrome: a rare cause of multi-organ failure in a man with complicated myocardial infarction.
Topics: Anesthetics, Intravenous; Humans; Male; Middle Aged; Multiple Organ Failure; Myocardial Infarction; | 2008 |
Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3beta.
Topics: Action Potentials; Anesthetics, Intravenous; Animals; Cardiotonic Agents; Coronary Circulation; Glyc | 2008 |
Functional comparison of anaesthetic agents during myocardial ischaemia-reperfusion using pressure-volume loops.
Topics: Anesthetics; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Desflurane; Drug Evaluation | 2009 |
Cardioprotective effects of anesthetic preconditioning in rats with ischemia-reperfusion injury: propofol versus isoflurane.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Apoptosis; Cardiotonic Agents; Drug Inte | 2009 |
Propofol inhibits desflurane-induced preconditioning in rabbits.
Topics: Animals; Desflurane; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Myocardial Infarction; | 2011 |
Propofol induced marked prolongation of QT interval in a patient with acute myocardial infarction.
Topics: Aged; Anesthetics, Intravenous; Electrocardiography; Female; Humans; Myocardial Infarction; Propofol | 2002 |
Effects of propofol, midazolam and thiopental sodium on outcome and amino acids accumulation in focal cerebral ischemia-reperfusion in rats.
Topics: Adenosine Triphosphate; Animals; Brain; Brain Edema; Brain Ischemia; Excitatory Amino Acids; Male; M | 2003 |
Narcolepsy and cardiac surgery: can anesthesia with propofol and remifentanil be safe?
Topics: Aged; Anesthesia, General; Anesthetics, Intravenous; Atracurium; Cardiac Surgical Procedures; Cardio | 2004 |
Difficult extubation: calming the sympathetic storm.
Topics: Aged; Conscious Sedation; Device Removal; Dexmedetomidine; Humans; Hypertension; Hypnotics and Sedat | 2004 |
Negative inotropic action of propofol is enhanced in the acute ischemic myocardium of dogs.
Topics: Animals; Calcium; Cerebrovascular Circulation; Chloralose; Depression, Chemical; Dogs; Myocardial Co | 2005 |
Dental management of a patient with takotsubo cardiomyopathy: a case report.
Topics: Adult; Anesthesia, Dental; Anesthetics, Intravenous; Cardiomyopathies; Conscious Sedation; Dental Ca | 2007 |
The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures.
Topics: Aged; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Arrhythmias, Cardiac; | 2007 |
The effects of propofol on cardiac function after 4 hours of cold cardioplegia and reperfusion.
Topics: Anesthetics, Intravenous; Animals; Apoptosis; Bradykinin; Coronary Vessels; Glucose; Heart; Heart Ar | 2007 |
Fatal myocardial failure associated with a propofol infusion in a child.
Topics: Child; Conscious Sedation; Humans; Myocardial Infarction; Propofol | 1995 |
Thyrotoxicosis factitia in a post-aortocoronary bypass patient.
Topics: Adrenergic beta-Antagonists; Amrinone; Angina, Unstable; Coronary Artery Bypass; Humans; Isoquinolin | 1994 |
Does ketamine/propofol anesthesia possess antiarrhythmogenic quality? A perioperative study in aortocoronary bypass patients.
Topics: Aged; Anti-Arrhythmia Agents; Body Temperature Regulation; Coronary Artery Bypass; Electrocardiograp | 2001 |